- Home
- BCRX vs ASTH Comparison
BCRX vs ASTH Comparison
Compare BCRX & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- ASTH
- Stock Information
- Founded
- BCRX 1986
- ASTH 1994
- Country
- BCRX United States
- ASTH United States
- Employees
- BCRX N/A
- ASTH N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- ASTH Professional Services
- Sector
- BCRX Health Care
- ASTH Consumer Discretionary
- Exchange
- BCRX Nasdaq
- ASTH Nasdaq
- Market Cap
- BCRX 1.9B
- ASTH 1.7B
- IPO Year
- BCRX 1994
- ASTH N/A
- Fundamental
- Price
- BCRX $8.66
- ASTH $23.22
- Analyst Decision
- BCRX Strong Buy
- ASTH Strong Buy
- Analyst Count
- BCRX 10
- ASTH 8
- Target Price
- BCRX $16.70
- ASTH $53.29
- AVG Volume (30 Days)
- BCRX 3.2M
- ASTH 281.5K
- Earning Date
- BCRX 08-04-2025
- ASTH 08-06-2025
- Dividend Yield
- BCRX N/A
- ASTH N/A
- EPS Growth
- BCRX N/A
- ASTH N/A
- EPS
- BCRX N/A
- ASTH 0.73
- Revenue
- BCRX $503,485,000.00
- ASTH $2,250,574,000.00
- Revenue This Year
- BCRX $38.50
- ASTH $41.46
- Revenue Next Year
- BCRX $10.04
- ASTH $23.97
- P/E Ratio
- BCRX N/A
- ASTH $31.39
- Revenue Growth
- BCRX 41.67
- ASTH 54.81
- 52 Week Low
- BCRX $6.02
- ASTH $22.58
- 52 Week High
- BCRX $11.31
- ASTH $63.20
- Technical
- Relative Strength Index (RSI)
- BCRX 35.06
- ASTH 41.38
- Support Level
- BCRX $8.40
- ASTH $22.58
- Resistance Level
- BCRX $8.79
- ASTH $25.69
- Average True Range (ATR)
- BCRX 0.25
- ASTH 1.11
- MACD
- BCRX -0.00
- ASTH -0.12
- Stochastic Oscillator
- BCRX 18.07
- ASTH 24.22
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.